Logo 6 a1e69dad97a22b9caa5aa6c606f6ea7f9e9b8c4d0352141ae8a7e9bed5512ee3
  • Antibodies
  • Assays/Kits
  • Proteins/Peptides
  • siRNAs/Functional Genomics
  • Biochemicals
  • cDNA Clones
  • Cell/Tissue/Blood Products
  • Genes
  • Images

CFM-2

Name CFM-2
Supplier Tocris Bioscience
Catalog 5144
Prices $189.00, $765.00
Sizes 10 mg, 50 mg
Function Type Antagonist
Cas Number 178616-26-7
Chemical Name 1-(4'-Aminophenyl)-3,5-dihydro-7,8-dimethoxy-4H-2,3-benzodiazepin-4-one
Formula C17H17N3O3
Molecular Weight 311.34
Purity >98 %
Description Novel, selective non-competitive AMPA antagonist. Highly potent, long-acting anticonvulsant.
Supplier Page Shop

Product References

1-Aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: novel AMPA receptor antagonists. - 1-Aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: novel AMPA receptor antagonists.

Chimirri A, De Sarro G, De Sarro A, Gitto R, Grasso S, Quartarone S, Zappala M, Giusti P, Libri V, Constanti A, Chapman AG. J Med Chem. 1997 Apr 11;40(8):1258-69.

Effects of some AMPA receptor antagonists on the development of tolerance in - Effects of some AMPA receptor antagonists on the development of tolerance in

De Sarro G, Di Paola ED, Gareri P, Gallelli L, Scotto G, De Sarro A. Eur J Pharmacol. 1999 Mar 5;368(2-3):149-59.

Anticonvulsant activity and plasma level of 2,3-benzodiazepin-4-ones (CFMs) in - Anticonvulsant activity and plasma level of 2,3-benzodiazepin-4-ones (CFMs) in

De Sarro G, Rizzo M, Spagnolo C, Gitto R, De Sarro A, Scotto G, Zappala M, Chimirri A. Pharmacol Biochem Behav. 1999 Aug;63(4):621-7.



Privacy
Terms
About us
Contact us

Copyright© 2025. All Rights Reserved